BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23083587)

  • 1. MRI in high risk women: benefits and problems.
    Cortesi L; Pecchi A; De Matteis E; Filieri E; Battista R; Canossi B; Torricelli P; Federico M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S19-20. PubMed ID: 23083587
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast magnetic resonance imaging for screening high-risk women.
    Sung JS; Dershaw DD
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):509-17. PubMed ID: 23928241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?
    Trecate G; Agresti R; Suman L; Vergnaghi D; Valeri B; Marchesini M; Ferranti C; Ferraris C; Manoukian S; Scaperrotta G; ViganĂ² S; Panizza P
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S165-70. PubMed ID: 23083576
    [No Abstract]   [Full Text] [Related]  

  • 4. Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.
    Kam JK; Naidu P; Rose AK; Mann GB
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):400-6. PubMed ID: 23870334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-negative MRI breast screening in high-risk women.
    Maxwell AJ; Lim YY; Hurley E; Evans DG; Howell A; Gadde S
    Clin Radiol; 2017 Mar; 72(3):207-216. PubMed ID: 27932250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI in B3 lesions, low grade DCIS, high DCIS: is MR selecting the dangerous cases?
    Zuiani C; Londero V; Linda A; Girometti R; Bazzocchi M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S189-91. PubMed ID: 23083586
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates.
    Pediconi F; Miglio E; Telesca M; Luciani ML; Kirchin MA; Passariello R; Catalano C
    Invest Radiol; 2012 Feb; 47(2):128-35. PubMed ID: 21934515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening high risk women with MRI alone?
    Sardanelli F; Santoro F; Podo F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S137-8. PubMed ID: 23083564
    [No Abstract]   [Full Text] [Related]  

  • 11. JOURNAL CLUB: Is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results.
    Arazi-Kleinman T; Skair-Levy M; Slonimsky E; Maly B; Uziely B; Libson E; Sella T
    AJR Am J Roentgenol; 2013 Oct; 201(4):919-27. PubMed ID: 24059385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI scanning increases eightfold in Canadian women with breast cancer.
    Wise J
    BMJ; 2015 Sep; 351():h5088. PubMed ID: 26415937
    [No Abstract]   [Full Text] [Related]  

  • 14. The negative predictive value of breast Magnetic Resonance Imaging in noncalcified BIRADS 3 lesions.
    Dorrius MD; Pijnappel RM; Sijens PE; van der Weide MC; Oudkerk M
    Eur J Radiol; 2012 Feb; 81(2):209-13. PubMed ID: 21251784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of women at high risk for breast cancer.
    Narod SA
    Prev Med; 2011 Sep; 53(3):127-30. PubMed ID: 21745498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-related factors in breast cancer: an underappreciated piece of the puzzle?
    Goodwin PJ
    J Clin Oncol; 2008 Jul; 26(20):3299-300. PubMed ID: 18612145
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience.
    Elmore L; Margenthaler JA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():263-7. PubMed ID: 20853044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we use MR-mammography to predict nodal status?
    Carbonaro LA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S17-8. PubMed ID: 23083577
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer screening in women: An integrative literature review.
    Ravert PK; Huffaker C
    J Am Acad Nurse Pract; 2010 Dec; 22(12):668-73. PubMed ID: 21129075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.